Is uncertainty really stymieing growth? The leaders of Fortune 500 companies are sitting on trillions in cash awaiting clear indicators of where the economy is going. The stock market drops precipitously on the slightest hint of a problem. Business leaders of companies, large and small, say that they aren’t hiring because of the uncertainty over future healthcare costs.
Do these concerns reflect good business sense or the lack of will to lead?Read More
‘Industry leader’ is one of the financial press’ favorite phrases, yet how often do they define the term? What makes one company, above all others, the industry leader? More importantly, why should you care?Read More
GM reported a record $7.6 billion profit for 2011. Politician’s hailed this is as proof positive that the bailout worked. Is it truly a cause celebre?Read More
A recent Washington Post/Bloomberg Business article stated that Hormel Foods fourth quarter 2011 profit slipped 3%. Price increases were blamed for lower sales volumes. Tyson Foods experienced a similar fate with its fourth quarter results.
Does this news fly in the face of my September 19, 2011 post Higher Prices = Lost Customers? in which I cited business owners whose price increases resulted in growth in their customer bases?Read More
“Essentially all of the drug shortages that occur in the U.S. arise in the generics market, where profitability is fairly low,” Greg Conko, of the Competitive Enterprise Institute in Washington, said by email in response to a request for comment from MedPage Today and ABC News.Read More